SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biosource International

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Richmann who wrote (206)9/15/1997 3:39:00 PM
From: Bob Richmann   of 696
 
Biosource got mentioned in the Red Chip Review Investors Conference and had the following text attached to the press release:

Biosource International, Inc. (Nasdaq:BIOI) Red Chip Rating C
Biosource develops, manufactures, markets and distributes products that are widely used in biomedical research and instrumental in the development of new medical diagnostic methods and pharmaceutical products. Foreign currency pressures experienced in Q1 and Q2 lessened in Q3. BIOI's highly diversified customer base, new product introductions and a projected industry growth of 20%+ point to a strong rebound.

It was the only one of about 10 companies with a rating of C (most were Bs a couple of As) but still being mentioned as a C rated stock is probably better than not being mentioned at all. Trading up 1/4.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext